Theradiag Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Simon Daviere

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

Recent updates

Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch

Oct 04
Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch

Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger

Oct 03
Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger

Theradiag (EPA:ALTER) Is Carrying A Fair Bit Of Debt

Oct 26
Theradiag (EPA:ALTER) Is Carrying A Fair Bit Of Debt

CEO

Simon Daviere (39 yo)

less than a year

Tenure

Mr. Simon Davière is Chief Executive Officer of Theradiag SA from March 01, 2023 and also serves as its General Manager since 2023. He holds an engineering degree in Biological Engineering from the Univers...


Board Members

NamePositionTenureCompensationOwnership
Christian Policard
Independent Chairmanless than a yearno datano data
Larry Abensur
Director1.6yrsno datano data
Thierry Paper
Director1.6yrsno datano data
Jacques Azancot
Independent Director1.5yrsno datano data

1.5yrs

Average Tenure

Experienced Board: ALTER's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/21 13:29
End of Day Share Price 2023/12/21 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Theradiag SA is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pierre BouchenyKepler Cheuvreux
Arnaud GuérinPortzamparc BNP Paribas